How Much Testosterone Cream Should a Woman Use?

Most clinical guidelines and trial data point to a transdermal testosterone dose that delivers roughly 300 micrograms per day for women, which is about one-tenth of a typical male dose. Because no testosterone product is currently approved by the FDA specifically for women, prescribers typically adapt male formulations or rely on compounded creams, making the “how much” question trickier than it sounds. The dose, the formulation, and where you apply it all influence what your body actually absorbs, so the number on the tube is only part of the story.

The Target Dose and Why It Is So Small

Women naturally produce far less testosterone than men, and the goal of testosterone cream therapy is to nudge levels back into the range a woman would have had before menopause, not to push them higher. The International Society for the Study of Women’s Sexual Health (ISSWSH) guideline, which is the most widely referenced clinical practice document on the topic, states that government-approved transdermal male formulations can be used cautiously with dosing appropriate for women, and that total testosterone levels should be monitored to stay within the normal premenopausal range.¹ In practice, that means applying a pea-sized amount of cream or a fraction of a gel pump, typically delivering around 5 mg of testosterone or less to the skin each day, of which only a small percentage reaches the bloodstream.

A systematic review of high-quality trials found that 300 micrograms per day of transdermal testosterone was effective for managing hypoactive sexual desire disorder (HSDD) in both surgically and naturally menopausal women, with minimal side effects.² That 300-microgram figure is the amount that actually enters circulation, not the total amount smeared onto the skin. The cream itself may contain considerably more testosterone, because the skin only absorbs a fraction of what is applied.

Why There Is No Simple Label to Follow

No testosterone cream, gel, or patch currently carries FDA approval for use in women with HSDD, despite years of research showing benefit. Clinicians prescribing it do so off-label, which means they are adapting a product designed and dosed for men, or writing a prescription for a compounding pharmacy to prepare a custom formulation.³ Either route has implications for dosing accuracy.

If your doctor prescribes a male testosterone gel (commonly sold in pumps delivering 10 mg or 20.25 mg per full pump), you will use a small fraction of a pump. Getting a consistent one-tenth of a pump press every morning is not easy, and some women end up with variable doses day to day. Compounded creams solve this by being mixed at a lower concentration, so one full application delivers the intended female dose. However, compounded formulations are unregulated and have documented problems with potency, consistency, and stability from batch to batch, which raises concerns about unpredictable absorption.⁴

The practical takeaway is that no matter which formulation you use, blood-level monitoring is essential. You cannot rely on the label alone to know what your body is actually getting.

Where You Apply It Matters

Testosterone cream is typically applied to the inner thigh, lower abdomen, or upper arm. Some formulations, especially compounded ones aimed at treating vulvovaginal symptoms, are applied directly to vulvar skin. The site of application changes how much testosterone crosses into the bloodstream. A study comparing absorption at different body sites found that testosterone absorption through vulvar skin was significantly higher than through forearm skin, and this effect was especially pronounced in postmenopausal women.⁵

This means the same cream applied to the vulva could deliver a meaningfully larger dose to the bloodstream than the same cream applied to the thigh. If your prescriber switches you from one application site to another, your effective dose changes even if the cream concentration stays the same. This is one of the reasons follow-up blood work matters more than the number printed on the tube.

Monitoring and Keeping Levels in Range

The ISSWSH guideline recommends checking total testosterone levels to make sure they stay within the physiologic premenopausal range, which is generally considered to be somewhere below roughly 70 ng/dL for total testosterone, though labs vary slightly in their reference intervals.⁶ Your prescriber should also check liver function and a fasting lipid panel before you start, because liver disease and elevated lipids are considered contraindications.

A practical detail that can trip up monitoring: the timing of your blood draw relative to your last application matters. Testosterone cream produces a spike in blood levels within a few hours of application, then falls. If you apply the cream in the morning and have blood drawn two hours later, the number will look very different from blood drawn 20 hours later. Your clinician should standardize the timing so that repeat tests are comparable.

Researchers have also been exploring dried blood spot sampling as a more convenient way to track testosterone levels in women using low doses, rather than requiring a full venous blood draw each time.⁷ This is not yet standard practice, but it may become an option in the future.

What Testosterone Cream Is Prescribed For

The primary evidence-based use of testosterone cream in women is for hypoactive sexual desire disorder, which is a persistent, distressing loss of sexual desire that is not explained by relationship problems, medications, or other medical conditions. Multiple randomized, controlled trials in both surgically and naturally postmenopausal women have shown that testosterone improves the frequency of satisfying sexual events, as well as desire, arousal, and orgasm.⁸ The strongest evidence is in women who have undergone surgical menopause (removal of ovaries), which causes a sharp drop in testosterone production, but data also support benefit in naturally menopausal women and even some premenopausal women with low testosterone and reduced sexual satisfaction.⁹

Beyond sexual function, a pilot study of transdermal testosterone therapy in peri- and postmenopausal women found that mood and cognitive symptoms also improved after four months. Loss of interest in most things improved in over half of participants, and crying spells improved at a similar rate. Memory problems were the least likely to improve, with about a third of women reporting benefit.¹⁰ These mood and cognition findings are still preliminary, though, and current guidelines recommend testosterone specifically for HSDD rather than as a general menopause treatment.

Side Effects When the Dose Is Too High

Staying within the physiologic female range is the whole point of careful dosing. When testosterone levels creep above that range, androgenic side effects start showing up. These can include acne, increased facial or body hair growth, oily skin, and deepening of the voice. The voice change is particularly concerning because it can be irreversible, even after the cream is stopped. Clitoral enlargement is another possible effect of prolonged supraphysiologic dosing, and it too can be slow to reverse.

At the doses studied in clinical trials, around 300 micrograms per day, these side effects are uncommon. A dose of 5 mg or less of transdermal testosterone daily, followed by close monitoring, has been suggested as a reasonable upper boundary for clinical use, with the understanding that any sign of androgen excess warrants reassessment.¹¹ If you notice new acne, coarse hairs where you did not have them before, or a voice that sounds different to you, these are signals to call your prescriber rather than waiting for your next scheduled visit.

Cardiovascular and Lipid Considerations

One of the persistent concerns around testosterone therapy in women has been its effect on cholesterol and cardiovascular risk. The evidence here splits clearly by how the testosterone is delivered. A large meta-analysis found that oral testosterone led to a rise in LDL cholesterol and drops in total cholesterol, HDL cholesterol, and triglycerides, but these lipid changes were not seen with non-oral routes like patches or creams.¹² This is one of the reasons transdermal cream is the preferred delivery method over pills.

A smaller study specifically looking at postmenopausal women treated with testosterone gel found that total cholesterol and LDL cholesterol both dropped after six months, with no changes in triglycerides, HDL, or other lipid markers.¹³ That said, the ISSWSH guideline still recommends a baseline fasting lipid panel and treats hyperlipidemia as a relative contraindication, because long-term cardiovascular data in women remain limited.

How Estrogen Therapy Interacts with Testosterone

Many women who are prescribed testosterone cream are already taking estrogen replacement therapy. The interaction between the two hormones is worth understanding, because oral estrogen raises levels of a protein called sex hormone-binding globulin (SHBG), which binds testosterone and makes it less available to tissues. A study comparing oral and transdermal estrogen found that oral estrogen significantly increased SHBG within the first year, while transdermal estrogen did not, and free testosterone levels diverged between the two groups over time.¹⁴

In plain terms, if you are taking estrogen by mouth, a larger portion of any testosterone you apply topically will get bound up and rendered inactive. Your prescriber may need to adjust your testosterone dose upward to compensate, or switch you to a transdermal estrogen patch to avoid the SHBG increase altogether. A separate study tested oral estrogen plus testosterone gel in postmenopausal women and found that total testosterone levels rose in the testosterone group, but free and bioavailable testosterone did not increase significantly, consistent with the SHBG-binding problem.¹⁵

Transfer Risk to Partners, Children, and Pets

Testosterone cream stays on the skin surface for hours after the alcohol or carrier vehicle evaporates. If another person or a pet has prolonged skin-to-skin contact with the application site before you wash it off or cover it, they can absorb a meaningful amount of testosterone. Case reports have documented female partners developing signs of hyperandrogenism, most likely from skin contact with a male partner’s testosterone gel application site.¹⁶ In children, secondary exposure has been linked to early puberty, accelerated growth, and virilization; in animals, it has caused persistent estrus signs, poor growth, and birth defects.¹⁷

The doses involved in female testosterone therapy are much smaller than male testosterone replacement, which lowers the risk somewhat. One study testing interpersonal transfer from newly developed gel preparations concluded that, although testosterone does remain on intact skin for several hours, contamination of a second person causing actual side effects seemed unlikely at the levels tested.¹⁸ Still, covering the application site with clothing or washing hands after applying the cream is a reasonable precaution, particularly if you share a bed with a child or have pets that lick your skin.

Who Should Not Use Testosterone Cream

Testosterone cream is not appropriate for everyone. Women who are pregnant or who might become pregnant should not use it, because masculinization of a female fetus can occur in a highly androgenic environment. Women with hormone-dependent cancers, such as certain breast cancers, should only consider testosterone in close consultation with their oncologist. Liver disease and untreated hyperlipidemia are also listed as contraindications in the ISSWSH guideline.⁶

On the question of breast safety specifically, the concern is that testosterone can potentially be converted into estrogen by an enzyme called aromatase, which means exogenous testosterone could theoretically exert indirect estrogenic effects on breast tissue. Long-term safety data addressing this concern are still lacking.¹⁹ This uncertainty is why guidelines recommend against open-ended, unmonitored use and push for regular follow-up visits.

Effects Beyond Sexual Function

Though HSDD is the primary indication, women on testosterone therapy sometimes notice changes in body composition. A randomized, placebo-controlled study in young women given testosterone for ten weeks found that the testosterone group gained roughly 900 grams more lean mass than the placebo group, with the difference concentrated in the lower limbs.²⁰ Observational data in older women tell a similar story: higher free testosterone was associated with greater bone density at the hip, greater lean body mass, and, somewhat counterintuitively, greater total fat mass as well.²¹

These body-composition effects are not the reason testosterone is prescribed, but they are worth knowing about. If you notice your body feeling different, particularly increased muscle definition or changes in how your clothes fit, it is not unusual and does not necessarily mean your dose is too high. It is the androgenic side effects (acne, excess hair growth, voice changes) rather than modest shifts in lean mass that signal a dosing problem.

The Cost and Access Problem

Because testosterone therapy for women remains off-label in the United States, insurance coverage is inconsistent and often poor. Clinicians have noted that it is frequently more cost-effective for women to pay out of pocket rather than run the prescription through insurance, which can paradoxically increase the cost.³ Compounded formulations may be cheaper per month than dividing male gel products, but as noted earlier, they carry trade-offs in quality consistency. Some women end up cycling between compounding pharmacies and commercially available gels, trying to find the balance between cost, convenience, and dose reliability. Having a prescriber who is experienced with female testosterone therapy helps, because they will know which formulations their patients have had the best results with in terms of both clinical response and practicality.

1
PubMed. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
2
PubMed Central. Transdermal Testosterone in Female Hypoactive Sexual Desire Disorder: A Rapid Qualitative Systematic Review Using Grading of Recommendations Assessment, Development and Evaluation
3
PubMed. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
4
PubMed Central. The dangers of compounded bioidentical hormone replacement therapy
5
British Journal of Dermatology. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site
6
PubMed Central. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
7
ScienceDirect. Dried blood spot sampling of testosterone microdosing in healthy females
8
Clinical Obstetrics and Gynecology. Testosterone for Treating Female Sexual Dysfunction
9
PubMed. Role of testosterone in the treatment of hypoactive sexual desire disorder
10
PubMed Central. Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study
11
Acta Obstetricia et Gynecologica Scandinavica. The role of testosterone in menopausal hormone treatment. What is the evidence?
12
The Lancet Diabetes & Endocrinology. Testosterone therapy for women: a systematic review and meta-analysis
13
Endocrinología y Nutrición (English Edition). Lipid profile modifications in post-menopausal women treated with testosterone gel
14
PubMed. Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels
15
PubMed. Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women
16
PubMed. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies
17
PubMed Central. A review of adverse events in animals and children after secondary exposure to transdermal hormone-containing medicinal products
18
PubMed. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation
19
Oxford Academic (Endocrine Reviews). Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
20
British Journal of Sports Medicine. Effects of moderately increased testosterone concentration on physical performance in young women: a double blind, randomised, placebo controlled study
21
The Journal of Clinical Endocrinology & Metabolism. Higher Serum Free Testosterone Concentration in Older Women Is Associated with Greater Bone Mineral Density, Lean Body Mass, and Total Fat Mass: The Cardiovascular Health Study